HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Gelband, H. Articles by Seiter, A. Search for Related Content PubMed Articles by Gelband, H. Articles by Seiter, A.

A Global Subsidy for Antimalarial Drugs

In 2004, the Institute of Medicine concluded that a global high-level subsidy was the best way to make effective antimalarial drugs—currently, artemisinin-combination therapies (ACTs)—widely available at affordable prices and at the same time substantially delay the emergence and spread of artemisinin-resistant strains of falciparum malaria. The subsidy would be available to manufacturers of all ACTs meeting pre-specified efficacy, safety, and quality criteria. Buyers would pay very low prices, allowing drugs to flow through existing channels, with the aim of reaching consumers at a similar price to chloroquine, the most frequently used (although no longer effective) malaria drug. Unsubsidized artemisinin monotherapies would be more expensive than subsidized ACTs (co-formulations), thereby largely eliminating their use through market forces. Conditions favoring the emergence of artemisinin-resistant malaria would be greatly reduced. The global high-level subsidy is a powerful idea that is moving from economic concept to pragmatic reality.

Received December 29, 2006. Accepted for publication March 5, 2007.

^* Address correspondence to Hellen Gelband, Institute of Medicine, 500 5th Street NW, Room 853, Washington, DC, 20001. E-mail: HGelband{at}nas.edu

Authors’ addresses: H. Gelband, Institute of Medicine, 500 5th Street NW, Room 853, Washington, DC, 20001. A. Seiter, 1818 H St. NW, Washington DC 20433.

This article has been cited by other articles:

				J. G. Breman, M. S. Alilio, and N. J. White Defining and Defeating the Intolerable Burden of Malaria III. Progress and Perspectives Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): vi - xi. [Full Text] [PDF]